|
?:authorAffiliation
|
-
[\'Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.\', \'Immunisation and Countermeasures Division, National Infection Service, London, UK.\', \'Immunoassay Laboratory, National Infection Service, Porton Down, UK.\', \'Sero-epidemiology Unit, Public Health England, Public Health Laboratory Manchester, Manchester Medical Microbiology Partnership, Manchester Royal Infirmary, Manchester, UK.\', \'Department of Virology, Manchester Medical Microbiology Partnership, Manchester Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.\', \'The NIHR Manchester Clinical Research Facility, Manchester University NHS Foundation Trust, Manchester, UK.\', \'Kellgren Centre for Rheumatology, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.\', \'Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.\', \'Immunisation and Countermeasures Division, National Infection Service, London, UK. Shamez.Ladhani@phe.gov.uk.\', \'Paediatric Infectious Diseases Research Group (PIDRG), St. Georges University of London (SGUL), London, UK. Shamez.Ladhani@phe.gov.uk.\', \'Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. P.Moss@bham.ac.uk.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}